| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c539db959cc0106cab1662303f94fce |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18 |
| filingDate |
1998-08-14^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54fc1a0af1999fc47c0d1edc10991a17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9ab13c7ebe19d1f4350727fa993a30f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03e473a20fe89b04bb5fb406dddab681 |
| publicationDate |
2002-04-26^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-508502-A |
| titleOfInvention |
Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV) |
| abstract |
A compound of formula Ig, where: O-nuc is the residue of monohydroxyl bearing D- or L- nucleoside analogue; R2 is the residue of an aliphatic L-amino acid; p is 0, 1 or 2-20 (optionally including a double bond); and q is 0-5. The compound may be used in medicaments for the prophylaxis or treatment of viral infections. |
| priorityDate |
1997-08-15^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |